These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9617979)

  • 21. The antidepressant efficacy of zimelidine and maprotiline.
    Montgomery SA; Rani SJ; McAuley R; Roy D; Montgomery DB
    Acta Psychiatr Scand Suppl; 1981; 290():219-24. PubMed ID: 6452792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Obsessive and compulsive symptoms in schizophrenia: a randomized controlled trial with fluvoxamine and neuroleptics.
    Reznik I; Sirota P
    J Clin Psychopharmacol; 2000 Aug; 20(4):410-6. PubMed ID: 10917401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An open study of fluvoxamine augmentation of neuroleptics in schizophrenia with obsessive and compulsive symptoms.
    Reznik I; Sirota P
    Clin Neuropharmacol; 2000; 23(3):157-60. PubMed ID: 10895399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluvoxamine dose-dependent interaction with haloperidol and the effects on negative symptoms in schizophrenia.
    Yasui-Furukori N; Kondo T; Mihara K; Inoue Y; Kaneko S
    Psychopharmacology (Berl); 2004 Jan; 171(2):223-7. PubMed ID: 12955290
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fluvoxamine as effective as clomipramine against symptoms of severe depression: results from a multicentre, double-blind study.
    Zohar J; Keegstra H; Barrelet L
    Hum Psychopharmacol; 2003 Mar; 18(2):113-9. PubMed ID: 12590404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of maprotiline combined with conventional neuroleptics against negative symptoms of chronic schizophrenia.
    Yamagami S; Soejima K
    Drugs Exp Clin Res; 1989; 15(4):171-6. PubMed ID: 2570687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prediction of antidepressant response to milnacipran and fluvoxamine using pharmacogenetical methods].
    Higuchi H
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2010 Apr; 30(2):71-6. PubMed ID: 20491280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluvoxamine treatment of obsessive-compulsive symptoms in schizophrenic patients: an add-on open study.
    Poyurovsky M; Isakov V; Hromnikov S; Modai I; Rauchberger B; Schneidman M; Weizman A
    Int Clin Psychopharmacol; 1999 Mar; 14(2):95-100. PubMed ID: 10220124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of antidepressant treatment on platelet 5-HT content and relation to therapeutic outcome in unipolar depressive patients.
    Mück-Seler D; Jakovljević M; Deanović Z
    J Affect Disord; 1991 Nov; 23(3):157-64. PubMed ID: 1774431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic sleep deprivation and antidepressant medication in patients with major depression.
    Kasper S; Kick H; Voll G; Vieira A
    Eur Neuropsychopharmacol; 1991 May; 1(2):107-11. PubMed ID: 1821699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fluvoxamine augmentation of antipsychotics improves negative symptoms in psychotic chronic schizophrenic patients: a placebo-controlled study.
    Silver H; Barash I; Aharon N; Kaplan A; Poyurovsky M
    Int Clin Psychopharmacol; 2000 Sep; 15(5):257-61. PubMed ID: 10993127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antidepressant efficacy and tolerability of milnacipran, a dual serotonin and noradrenaline reuptake inhibitor: a comparison with fluvoxamine.
    Clerc G;
    Int Clin Psychopharmacol; 2001 May; 16(3):145-51. PubMed ID: 11354236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the Effect of Fluvoxamine in Patients With Schizophrenia Under Risperidone Treatment: A Clinical Trial.
    Haji Seyed Javadi A; Shafikhani AA; Zamir SM; Khanshir ZF
    J Clin Psychopharmacol; 2018 Apr; 38(2):119-124. PubMed ID: 29432331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluvoxamine in the treatment of panic disorder: a multi-center, double-blind, placebo-controlled study in outpatients.
    Asnis GM; Hameedi FA; Goddard AW; Potkin SG; Black D; Jameel M; Desagani K; Woods SW
    Psychiatry Res; 2001 Aug; 103(1):1-14. PubMed ID: 11472786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The involvement of BDNF-CREB signaling pathways in the pharmacological mechanism of combined SSRI- antipsychotic treatment in schizophrenia.
    Einoch R; Weinreb O; Mandiuk N; Youdim MBH; Bilker W; Silver H
    Eur Neuropsychopharmacol; 2017 May; 27(5):470-483. PubMed ID: 28410959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and tolerability of citalopram in comparison with fluvoxamine in depressed outpatients: a double-blind, multicentre study. The LUCIFER Group.
    Haffmans PM; Timmerman L; Hoogduin CA
    Int Clin Psychopharmacol; 1996 Sep; 11(3):157-64. PubMed ID: 8923094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment strategy in depression. I. Non-tricyclic and selective reuptake inhibitors in resistant depression: a double-blind partial crossover study on the effects of oxaprotiline and fluvoxamine.
    Nolen WA; van de Putte JJ; Dijken WA; Kamp JS; Blansjaar BA; Kramer HJ; Haffmans J
    Acta Psychiatr Scand; 1988 Dec; 78(6):668-75. PubMed ID: 3146890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-benefit & cost-effectiveness analysis of the rapid onset of selective serotonin reuptake inhibitors by augmentation.
    Tome MB; Isaac MT
    Int J Psychiatry Med; 1997; 27(4):377-90. PubMed ID: 9565733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [SSRI antidepressants and negative schizophrenic symptoms: differences between paroxetine and fluvoxamine in patients treated with olanzapine].
    Rusconi AC; Carlone C; Muscillo M; Coccanari de' Fornari MA; Podda L; Piccione M
    Riv Psichiatr; 2009; 44(5):313-9. PubMed ID: 20066819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fluvoxamine as an adjunctive agent in schizophrenia.
    Silver H
    CNS Drug Rev; 2001; 7(3):283-304. PubMed ID: 11607044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.